The FDA approved Addyi (flibanserin), a libido-enhancing drug, in postmenopausal women under the age of 65. Experts explain ...

Addyi, the first FDA-approved medication for low libido in women under 65, offers a new treatment option. Learn about its ...

HSDD affects 40%-55% of postmenopausal women, often due to hormonal changes, impacting sexual desire and quality of life.

Up until now, women who’d surpassed menopause and were dealing with frustratingly low libido—a.k.a. hypoactive sexual desire ...

You used to enjoy being intimate with your partner regularly, but lately you find yourself feeling "in the mood" less often. What’s going on? Actually, a lot. Especially for those of us in ...

The FDA expanded its approval of Addyi to treat low libido in postmenopausal women up to age 65. The approval will open up ...

The "little pink pill" is now available to even more women. The Food and Drug Administration (FDA) just approved Addyi for ...

Viagra, the little blue pill, has been a household name for more than a generation. And now women's sexual health is finally ...

A growing number of women are turning to testosterone treatments to ease their menopause symptoms — and save their sex lives.

For decades, sexologists have documented the substantial proportion of women who complain of low libido, known clinically as hypoactive sexual desire disorder (HSDD). Two landmark studies by ...

US wellness influencers are increasingly targeting birth control pills, pushing their followers to abandon the contraceptives with false claims about infertility and low libido that researchers say ...

With Monday's ruling, Addyi becomes the first and only FDA-approved pill for low sexual desire in postmenopausal women-an ...